HHLR ADVISORS, LTD.
SuperinvestorHHLR Advisors (Hillhouse)
- SEC CIK
- 0001762304
- Manager
- Zhang Lei
- Style
- Growth
PYXS holding history
Pyxis Oncology, Inc.
Every 13F filing in which HHLR Advisors (Hillhouse) reported holding PYXS, plus the quarters it sold out. Changes compare share counts with the previous calendar quarter.
PYXS overviewAll 13F holders of PYXSFull portfolio
| Quarter | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.00% | −382,606−100.0% | Sold out |
| Q4 2024 | 382,606 | $596.87K | 0.02% | 00.0% | Unchanged |
| Q3 2024 | 382,606 | $1.4M | 0.03% | 00.0% | Unchanged |
| Q2 2024 | 382,606 | $1.27M | 0.03% | 00.0% | Unchanged |
| Q1 2024 | 382,606 | $1.63M | 0.04% | 00.0% | Unchanged |
| Q4 2023 | 382,606 | $688.69K | 0.01% | 00.0% | Unchanged |
| Q3 2023 | 382,606 | $761.39K | 0.02% | 00.0% | Unchanged |
| Q2 2023 | 382,606 | $979.47K | 0.02% | −148,086−27.9% | Reduced |
| Q1 2023 | 530,692 | $2.13M | 0.04% | −233,714−30.6% | Reduced |
| Q4 2022 | 764,406 | $1.02M | 0.02% | 00.0% | Unchanged |
| Q3 2022 | 764,406 | $1.51M | 0.04% | 00.0% | Unchanged |
| Q2 2022 | 764,406 | $1.82M | 0.04% | 00.0% | Unchanged |
| Q1 2022 | 764,406 | $3.09M | 0.06% | 00.0% | Unchanged |
| Q4 2021 | 764,406 | $8.39M | 0.13% | +764,406 | New |